Development of a novel hyaluronic acid membrane for the treatment of ocular surface diseases
Abstract Ocular surface diseases (OSD) can cause serious visual deterioration and discomfort. Commercial artificial tear solution containing hyaluronic acid (HA) show excellent biocompatibility and unique viscoelastic characteristics. Here, we developed a novel HA membrane (HAM) by chemical crosslin...
Guardado en:
Autores principales: | Dong Ju Kim, Mi-Young Jung, Ha-Jin Pak, Joo-Hee Park, Martha Kim, Roy S. Chuck, Choul Yong Park |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/effb8fb41b86493b907ce6bb2b80c591 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Evaluation of moxifloxacin-induced cytotoxicity on human corneal endothelial cells
por: Joo-Hee Park, et al.
Publicado: (2021) -
Effect of Nitric Oxide on Human Corneal Epithelial Cell Viability and Corneal Wound Healing
por: Joo-Hee Park, et al.
Publicado: (2017) -
An Evaluation of the in vivo Safety of Nonporous Silica Nanoparticles: Ocular Topical Administration versus Oral Administration
por: Martha Kim, et al.
Publicado: (2017) -
Efficacy of carbomer sodium hyaluronate trehalose vs hyaluronic acid to improve tear film instability and ocular surface discomfort after cataract surgery
por: Caretti L, et al.
Publicado: (2019) -
Phytosome-hyaluronic acid systems for ocular delivery of L-carnosine
por: Abdelkader H, et al.
Publicado: (2016)